177 related articles for article (PubMed ID: 38131351)
1. Health disparities in gout.
Helget LN; Mikuls TR
Curr Opin Rheumatol; 2024 Mar; 36(2):120-125. PubMed ID: 38131351
[TBL] [Abstract][Full Text] [Related]
2. Racial and gender disparities among patients with gout.
Singh JA
Curr Rheumatol Rep; 2013 Feb; 15(2):307. PubMed ID: 23315156
[TBL] [Abstract][Full Text] [Related]
3. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
[TBL] [Abstract][Full Text] [Related]
4. Update on gout: new therapeutic strategies and options.
Terkeltaub R
Nat Rev Rheumatol; 2010 Jan; 6(1):30-8. PubMed ID: 20046204
[TBL] [Abstract][Full Text] [Related]
5. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.
Dehlin M; Jacobsson L; Roddy E
Nat Rev Rheumatol; 2020 Jul; 16(7):380-390. PubMed ID: 32541923
[TBL] [Abstract][Full Text] [Related]
6. Increasing trend of asymptomatic hyperuricemia under treatment with urate-lowering drugs in Japan.
Hakoda M; Kasagi F
Mod Rheumatol; 2019 Sep; 29(5):880-884. PubMed ID: 30175646
[No Abstract] [Full Text] [Related]
7. Gout and hyperuricemia.
Chilappa CS; Aronow WS; Shapiro D; Sperber K; Patel U; Ash JY
Compr Ther; 2010; 36():3-13. PubMed ID: 21229813
[TBL] [Abstract][Full Text] [Related]
8. Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data.
Koto R; Nakajima A; Horiuchi H; Yamanaka H
Mod Rheumatol; 2021 Jan; 31(1):261-269. PubMed ID: 32552370
[TBL] [Abstract][Full Text] [Related]
9. [Gout].
Tausche AK
Internist (Berl); 2021 May; 62(5):513-525. PubMed ID: 33721041
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.
Ito S; Torii T; Nakajima A; Iijima T; Murano H; Horiuchi H; Yamanaka H; Honda M
BMC Pediatr; 2020 Oct; 20(1):481. PubMed ID: 33059648
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
Gupta MK; Singh JA
Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
[TBL] [Abstract][Full Text] [Related]
12. Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
Schumacher HR; Sundy JS; Terkeltaub R; Knapp HR; Mellis SJ; Stahl N; Yancopoulos GD; Soo Y; King-Davis S; Weinstein SP; Radin AR;
Arthritis Rheum; 2012 Mar; 64(3):876-84. PubMed ID: 22223180
[TBL] [Abstract][Full Text] [Related]
13. The Management of Gout in Renal Disease.
Estiverne C; Mount DB
Semin Nephrol; 2020 Nov; 40(6):600-613. PubMed ID: 33678314
[TBL] [Abstract][Full Text] [Related]
14. Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices.
Roman YM
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079846
[TBL] [Abstract][Full Text] [Related]
15. Critical revision of the medical treatment of gout in Brazil.
Azevedo VF; Lopes MP; Catholino NM; Paiva EDS; Araújo VA; Pinheiro GDRC
Rev Bras Reumatol Engl Ed; 2017; 57(4):346-355. PubMed ID: 28743362
[TBL] [Abstract][Full Text] [Related]
16. What do I need to know about gout?
Becker MA; Ruoff GE
J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070
[TBL] [Abstract][Full Text] [Related]
17. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016.
Chen-Xu M; Yokose C; Rai SK; Pillinger MH; Choi HK
Arthritis Rheumatol; 2019 Jun; 71(6):991-999. PubMed ID: 30618180
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Safety of Urate Lowering Therapies.
Kang EH; Kim SC
Curr Rheumatol Rep; 2019 Jul; 21(9):48. PubMed ID: 31342190
[TBL] [Abstract][Full Text] [Related]
20. Chronic gout: epidemiology, disease progression, treatment and disease burden.
Brook RA; Forsythe A; Smeeding JE; Lawrence Edwards N
Curr Med Res Opin; 2010 Dec; 26(12):2813-21. PubMed ID: 21050059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
